Ropes & Gray advised Solid Biosciences on the transaction. Solid Biosciences (Nasdaq: SLDB), a biotechnology company specializing in genetic medicines for neuromuscular and cardiac diseases, announced...
Solid Biosciences’ Licensing Agreement with Armatus Bio
Solid Biosciences’ $109 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Solid Biosciences Inc. on the deal. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines...